Smartphone app aims to help black smokers with HIV kick the habit
NCT ID NCT05709002
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study tests a mobile app designed specifically for Black adults living with HIV who smoke daily. The app includes culturally tailored content and anxiety-reduction techniques to support quitting. Participants are randomly assigned to use either the tailored app or a standard quit-smoking app, and their progress is tracked with a smartphone-connected breathalyzer to confirm abstinence. The goal is to see if a personalized digital tool can improve quit rates in this high-risk group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mobile app (MASP+)
What this could lead to
If effective, this app could provide a scalable, tailored tool to help Black smokers with HIV quit, reducing smoking-related health disparities.
What could go wrong
This is a small early-stage trial (76 participants), so results may not apply broadly. The app's success depends on user engagement and may not outperform standard quit-smoking apps.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIGARETTE SMOKING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Foscenvivint for Liver Cirrhosis in HIV/HCV & He NCT07681089
- RSV Vaccine Trial for Pregnant Women with HIV (NCT06325657)
- #TranscendentHealth: Text program for trans yout NCT07681908
- HIV and Cerebral Small Vessel Disease Study NCT02210130
- Urine HPV Test for Cervical Cancer Screening (NCT05413798)
- Cervical Cancer Screening in Ethiopia: HPV Self- NCT07678047
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Thomas Street at Quentin Mease Health Center
Houston, Texas, 77004, United States